METHOD FOR MEASUREMENT OF HbA1c USING AMADORIASE THAT REACTS WITH GLYCATED PEPTIDE

Patent metadata

Field	Value
Publication number	US-2016274129-A1
Application number	US-201415031385-A
Country	US
Kind code	A1
Filing date	Oct 24, 2014
Priority date	Oct 25, 2013
Publication date	Sep 22, 2016
Grant date	—

Abstract

This invention provides an amadoriase that can react with a wide variety of glycated peptides generated upon hydrolysis of the β chain of hemoglobin Alc (HbAlc) to generate hydrogen peroxide, a method for measurement of HbAlc using such amadoriase, and a reagent kit for measurement of HbAlc using such amadoriase. Provided is an amadoriase obtained by substitution of one or more amino acids at positions corresponding to amino acids selected from the group consisting of amino acids 62, 63, 102, 106, 110, 113, and 355 in the amino acid sequence of the amadoriase derived from the genus Coniochaeta or the like which amadoriase is capable of oxidizing a wide variety of glycated peptides to generate hydrogen peroxide. Further provided is a method for measurement of HbAlc comprising using such amadoriase as well as a reagent kit for measurement of HbAlc comprising such amadoriase. This invention can provide a method for measurement of HbAlc that enables quantification of HbAlc to be performed rapidly, simply, and accurately with the use of a small amount of a protease and a kit used for such measurement. This invention can also provide a method for measurement of HbAlc that enables quantification of HbAlc to be performed rapidly, simply, and accurately, with high sensitivity with the use of a small amount of a protease and a kit used for such measurement.

First claim

1 . (canceled)

2 . A method for measurement of α-fructosyl peptide in a sample, said method comprising allowing an amadoriase capable of reacting with one or more α-fructosyl peptides selected from among (a) to (e) below to react with a sample comprising one or more α-fructosyl peptides selected from among (a) to (e) and measuring the amount of hydrogen peroxide generated or enzyme consumed in such reaction:
(a) α-fructosyl-valyl-histidyl-leucine (αF3P);
(b) α-fructosyl-valyl-histidyl-leucyl-threonine (αF4P);
(c) α-fructosyl-valyl-histidyl-leucyl-threonyl-proline (αF5P);
(d) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysine (αF8P); and
(e) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysyl-seryl-alanyl-valyl-threonyl-alanyl-leucyl-tryptophyl-glycine (αF16P).

3 . The method according to claim 2 , wherein the sample further comprises α-fructosyl-valine (αF1P), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P), the amadoriase is further capable of reacting with α-fructosyl-valine (αF1P)), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P), and the amount of hydrogen peroxide generated or enzyme consumed in such reaction is also measured.

4 . (canceled)

5 . The method of claim 2 , said method further comprising treating a sample with a protease to release a glycated peptide comprising one or more α-fructosyl peptides selected from among (a) to (e):
(a) α-fructosyl-valyl-histidyl-leucine (αF3P);
(b) α-fructosyl-valyl-histidyl-leucyl-threonine (αF4P);
(c) α-fructosyl-valyl-histidyl-leucyl-threonyl-proline (αF5P);
(d) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysine (αF8P); and
(e) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysyl-seryl-alanyl-valyl-threonyl-alanyl-leucyl-tryptophyl-glycine (αF16P).

6 . The method according to claim 5 , wherein α-fructosyl-valine (αF1P), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P) is further released by treatment with the protease, the amadoriase is one that is further capable of reacting with α-fructosyl-valine (αF1P), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P), and the amount of hydrogen peroxide generated or enzyme consumed in such reaction is also measured.

7 . The method for measurement according to 2 , 3 , 5 or 6 , wherein the amadoriase is derived from the genus Coniochaeta, Eupenicillium, Pyrenochaeta, Arthrinium, Curvularia, Neocosmospora, Cryptococcus, Phaeosphaeria, Aspergillus, Emericella, Ulocladium , or Penicillium.

8 . The method for measurement according to claim 2 , 3 , 5 or 6 , wherein the amadoriase is derived from Coniochaeta sp., Eupenicillium terrenum, Pyrenochaeta sp., Arthrinium sp., Curvularia clavata, Neocosmospora vasinfecta, Cryptococcus neoformans, Phaeosphaeria nodorum, Aspergillus nidulans, Emericella nidulans, Ulocladium sp., or Penicillium janthinelum.

9 . The method for measurement according to claim 2 , 3 , 5 or 6 , wherein the amadoriase is an amadoriase selected from the group consisting of (i) and (ii) below:
(i) an amadoriase comprising an amino acid sequence derived from the amino acid sequence as shown in SEQ ID NO: 141 by substitution, deletion, or addition of one or several amino acids; and
(ii) the amadoriase as defined in (i), wherein the amadoriase comprises an amino acid sequence having 70% or higher sequence identity with the amino acid sequence as shown in SEQ ID NO: 141 over the full length and having 90% or higher sequence identity between the amino acid sequence of a homologous region consisting of amino acids at positions 10 to 32, 36 to 41, 49 to 52, 54 to 58, 73 to 75, 84 to 86, 88 to 90, 120 to 122, 145 to 150, 156 to 162, 164 to 170, 180 to 182, 202 to 205, 207 to 211, 214 to 224, 227 to 230, 236 to 241, 243 to 248, 258 to 261, 266 to 268, 270 to 273, 275 to 287, 295 to 297, 306 to 308, 310 to 316, 324 to 329, 332 to 334, 341 to 344, 346 to 355, 357 to 363, 370 to 383, 385 to 387, 389 to 394, 405 to 410, and 423 to 431 of SEQ ID NO: 141 and the amino acid sequence of the homologous region in corresponding positions of the amadoriase.

10 . The method according to claim 2 or 5 , further comprising using an amadoriase that oxidizes α-fructosyl-valine or α-fructosyl-valyl-histidine.

11 . (canceled)

12 . A reagent kit for measurement of α-fructosyl peptide in a sample, said kit comprising ingredients (1) and (2) below:
(1) an amadoriase that has activity of oxidizing a glycated peptide comprising one or more α-fructosyl peptides selected from among (a) to (e) to generate hydrogen peroxide; and
(2) a reagent for measurement of hydrogen peroxide:

(a) α-fructosyl-valyl-histidyl-leucine (αF3P);
(b) α-fructosyl-valyl-histidyl-leucyl-threonine (αF4P);
(c) α-fructosyl-valyl-histidyl-leucyl-threonyl-proline (αF5P);
(d) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysine (αF8P); and
(e) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysyl-seryl-alanyl-valyl-threonyl-alanyl-leucyl-tryptophyl-glycine (αF16P).

13 . The kit according to claim 12 , wherein the amadoriase further has activity of oxidizing α-fructosyl-valine (αF1P), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P) to generate hydrogen peroxide.

14 . (canceled)

15 . The kit of claim 12 , further comprising
(1) a protease that is capable of hydrolyzing the β chain of HbAlc to release a glycated peptide comprising one or more α-fructosyl peptides selected from among (a) to (e);
(a) α-fructosyl-valyl-histidyl-leucine (αF3P);
(b) α-fructosyl-valyl-histidyl-leucyl-threonine (αF4P);
(c) α-fructosyl-valyl-histidyl-leucyl-threonyl-proline (αF5P);
(d) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysine (αF8P); and
(e) α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamyl-glutamyl-lysyl-seryl-alanyl-valyl-threonyl-alanyl-leucyl-tryptophyl-glycine (αF16P).

16 . The kit according to claim 15 , wherein (1) the protease is further capable of hydrolyzing the HbAlc β chain to release α-fructosyl-valine (αF1P)), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P) and (2) the amadoriase further has activity of oxidizing α-fructosyl-valine (αF1P)), α-fructosyl-valyl-histidine (αF2P) and/or α-fructosyl-valyl-histidyl-leucyl-threonyl-proryl-glutamic acid (αF6P) to generate hydrogen peroxide.

17 . The kit according to claim 12 , 13 , 15 or 16 , wherein the amadoriase is derived from the genus Coniochaeta, Eupenicillium, Pyrenochaeta, Arthrinium, Curvularia, Neocosmospora, Cryptococcus, Phaeosphaeria, Aspergillus, Emericella, Ulocladium , or Penicillium.

18 . The kit according to claim 12 , 13 , 15 or 16 , wherein the amadoriase is an amadoriase selected from the group consisting of (i) and (ii) below:
(i) an amadoriase comprising an amino acid sequence derived from the amino acid sequence as shown in SEQ ID NO: 141 by substitution, deletion, or addition of one or several amino acids; and
(ii) the amadoriase as defined in (i), wherein the amadoriase comprises an amino acid sequence having 70% or higher sequence identity with the amino acid sequence as shown

Assignees

• Kikkoman Corp

Inventors

• Ichiyanagi Atsushi

Classifications

• C12Q1/26 Primary

  involving oxidoreductase · CPC title

• G01N2333/90672

  with oxygen as acceptor (1.5.3) in general · CPC title

• C12N9/0032

  with oxygen as acceptor (1.5.3) · CPC title

• G01N33/723 Primary

  Glycosylated haemoglobin · CPC title

• C07K14/37

  from fungi · CPC title